Alderbio Holdings LLC

Betty Yu-Ching Chang

John A Latham

Leon F Garcia-Martinez

Benjamin H Dutzar

Brian Robert Kovacevich

Ethan Wayne Ojala

Patricia Dianne McNeill

Pei Fan

Jens J Billgren

Erica Ann Stewart

Danielle Mitchell

Corinne C Akatsuka

Leon F Garcia-martinez

Jeffrey TL Smith

Danielle M Mitchell

The present invention is directed to antibodies and fragments thereof having binding specificity for NGF. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-NGF antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-NGF antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-NGF antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with NGF.

Anti-NGF compositions and use thereof

The present invention is directed to antibodies and fragments thereof having binding specificity for NGF. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-NGF antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making anti-NGF antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-NGF antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with NGF.

Growing community of inventors

Cupertino, CA, United States of America

Betty Yu-Ching Chang